BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term predictors of MS-related disability. Here we investigated the potential of whole-brain diffusivity and brain volume for the prediction of cross-sectional disability and short- to medium-term clinical evolution. MATERIALS AND METHODS: In this multimodal prospective longitudinal MRI study of 54 patients with MS (87% under immunomodulatory therapy, baseline and follow-up at a median of 12 months), ADC histogram analysis, WM lesion load, BPF, whole-brain atrophy rate, MSFC score, and EDSS score were obtained. A total of 44 patients with no relapse at both time points were included. RESULTS: At both time points, ADC histogram analysis provided robust predictors of the MSFC scores (maximal R(2) = 0.576, P < .001), incorporated cognition and fine-motor skill subscores, and EDSS scores. Significant changes beyond physiologic age-related changes at follow-up were noted for ADC histogram markers and BPF. Stronger diffusivity alterations and brain volume at baseline predicted MSFC decline, as demonstrated by multiple linear regression analysis (mean ADC, R(2) = 0.203; P = .003) and lower baseline BPF in patients with declined compared with stable MSFC scores (P = .001). Results were independent of intercurrent relapses. CONCLUSIONS: Diffusion histogram analysis provided stable surrogates of disability in MS and proved sensitive for monitoring disease progression during a median of 12 months. Advanced neuroaxonal pathology at baseline was indicative of an increased risk for sustained progression during a median of 12 months, independent of intercurrent relapses.
BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term predictors of MS-related disability. Here we investigated the potential of whole-brain diffusivity and brain volume for the prediction of cross-sectional disability and short- to medium-term clinical evolution. MATERIALS AND METHODS: In this multimodal prospective longitudinal MRI study of 54 patients with MS (87% under immunomodulatory therapy, baseline and follow-up at a median of 12 months), ADC histogram analysis, WM lesion load, BPF, whole-brain atrophy rate, MSFC score, and EDSS score were obtained. A total of 44 patients with no relapse at both time points were included. RESULTS: At both time points, ADC histogram analysis provided robust predictors of the MSFC scores (maximal R(2) = 0.576, P < .001), incorporated cognition and fine-motor skill subscores, and EDSS scores. Significant changes beyond physiologic age-related changes at follow-up were noted for ADC histogram markers and BPF. Stronger diffusivity alterations and brain volume at baseline predicted MSFC decline, as demonstrated by multiple linear regression analysis (mean ADC, R(2) = 0.203; P = .003) and lower baseline BPF in patients with declined compared with stable MSFC scores (P = .001). Results were independent of intercurrent relapses. CONCLUSIONS: Diffusion histogram analysis provided stable surrogates of disability in MS and proved sensitive for monitoring disease progression during a median of 12 months. Advanced neuroaxonal pathology at baseline was indicative of an increased risk for sustained progression during a median of 12 months, independent of intercurrent relapses.
Authors: Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi Journal: Arch Neurol Date: 2005-09
Authors: M Rovaris; E Judica; A Gallo; B Benedetti; M P Sormani; D Caputo; A Ghezzi; E Montanari; A Bertolotto; G Mancardi; R Bergamaschi; V Martinelli; G Comi; M Filippi Journal: Brain Date: 2006-08-18 Impact factor: 13.501
Authors: J H Simon; L D Jacobs; M K Campion; R A Rudick; D L Cookfair; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; N Simonian; M Lajaunie; D E Miller; K Wende; A Martens-Davidson; R P Kinkel; F E Munschauer; C M Brownscheidle Journal: Neurology Date: 1999-07-13 Impact factor: 9.910
Authors: Nicola De Stefano; Giuseppe Iannucci; Maria P Sormani; Leonello Guidi; Maria L Bartolozzi; Giancarlo Comi; Antonio Federico; Massimo Filippi Journal: J Neurol Date: 2002-08 Impact factor: 4.849
Authors: M Tiberio; D T Chard; D R Altmann; G Davies; C M Griffin; W Rashid; J Sastre-Garriga; A J Thompson; D H Miller Journal: Neurology Date: 2005-03-22 Impact factor: 9.910
Authors: A Beer; V Biberacher; P Schmidt; R Righart; D Buck; A Berthele; J Kirschke; C Zimmer; B Hemmer; M Mühlau Journal: J Neurol Date: 2016-05-13 Impact factor: 4.849